Diabetes
Conference Coverage
Respiratory infections, asthma rise before type 2 diabetes
Taken together, the data suggest that subacute inflammation manifesting in asthma as well as the onset of asthma or an acute infection may be a...
Conference Coverage
Precision medicine takes individual approach to diabetes
“Because diabetes is an incredibly heterogeneous disease, few people are Mr. or Mrs. ‘average’ and one-size-fits-all approaches fail many people...
Commentary
Social media makes kids with type 1 diabetes feel less alone
I have had numerous patients – many of whom have struggled to accept their diagnosis – mention with joy and excitement that they were following an...
Conference Coverage
Weight loss with semaglutide maintained for up to 3 years
“Importantly, these effects were sustained for up to 3 years, supporting the use of once weekly semaglutide for the long-term management of type 2...
Conference Coverage
Tirzepatide with insulin glargine improves type 2 diabetes
“Demonstrating superiority over insulin lispro in terms of the so-called trio of A1c, weight loss, and hypoglycemic events, tirzepatide offers...
Conference Coverage
Metformin treatment shows benefit in gestational diabetes
“Gestational diabetes is now reaching epidemic proportions. And of course, the vast majority of these women are in low- and middle-income...
Conference Coverage
Menstruation linked to underdiagnosis of type 2 diabetes?
The analysis estimates that an additional 17% of undiagnosed women younger than 50 years could be reclassified as having type 2 diabetes.
Commentary
Can zoo poo help manage diabetic foot ulcers?
The unexpected ingredient in this potentially transformative therapy? Feces from endangered species, sourced from Yorkshire Wildlife Park.
Commentary
When to prescribe semaglutide?
When considering an antiobesity medication for a patient, it’s important to discuss efficacy, side-effect profile, contraindications, cost and...
From the Journals
Support tool reduces hypoglycemia risk in type 2 diabetes
The tool was developed to help guide shared decision making for a goal A1c level, potential changes to treatment, and other steps to reduce the...
News from the FDA/CDC
FDA gives semaglutide two drug safety–related label changes
The second addition concerns a new adverse reaction that was identified during the postmarketing experience: gastrointestinal ileus, an intestinal...